精品国产一区二区三区免费,天天操天天日天天吻夜夜吻,亚洲成年人免费网站观看,99部国产精品免费观看

歡迎進(jìn)入上海起發(fā)實(shí)驗(yàn)試劑有限公司!
產(chǎn)品展示

La (SSB) antigen

描述:Identity:La ribonucleoprotein, SSB antigen, Sj?gren syndrome antigen B.Source Material:Bovine thymus (New Zealand origin).Clinical Indications:Autoantibodies present in Sj?gren’s syndrome, systemic lu

更新時(shí)間:2016-11-11
訪問(wèn)次數(shù):2834
廠商性質(zhì):代理商
詳情介紹

La (SSB) ANTIGEN 
AROTEC_La-SSB_Product_Info.pdf Version/Date: B/04.05.20 
ATL01-02 La (SSB) antigen 0.20 mg 
ATL01-05 La (SSB) antigen 0.50 mg 
ATL01-10 1.0 mg 
_________________________________________________________________________________
Description of the Product
Purified from bovine thymus. After coating onto ELISA plates 
the product will bind autoantibodies to La (SSB). 
Purity: The La autoantigen (45-50 kDa) is more than 90% 
pure, as assessed by SDS polyacrylamide gel electrophoresis. 
Concentration: 0.1-1.0 mg protein/ml. 
Storage: The product is stabilised with 20% glycerol and 0.1% 
Micr-O-protectTM. Store at -20 o
C or below (long term) or at 
+4o
C (short term). Avoid repeated freezing and thawing. Mix 
thoroughly before use. 
Clinical and Biochemical Data 
Sjögren's syndrome (SS) is a common systemic autoimmune 
inflammatory disorder characterised by lymphocyte-mediated 
destruction of exocrine glands leading to diminished or absent 
glandular secretion1-4. SS may present as a primary disease 
or in association with other systemic autoimmune diseases 
(referred to as secondary SS). Autoantibodies to the La (SSB) 
antigen can be detected in the sera of up to 87% of patients 
with primary or secondary SS5,6. The presence of anti-La 
(SSB) autoantibodies usually coincides with the presence of 
anti-Ro (SSA) autoantibodies7
, however the fact that anti-Ro 
autoantibodies are far more common in other rheumatological 
conditions such as systemic lupus erythematosis (SLE) and 
mixed connective tissue disease (MCTD) suggests that anti-La 
is more specific for primary and secondary SS than anti-Ro8,9

Anti-La autoantibodies have also been reported to be present 
in other clinical conditions, most notably in the sera of mothers 
of infants with neonatal lupus syndrome10, but also in 10 to 
15% of SLE patients11,12

binds to the oligo(U) 3' termini of nascent 
RNA polymerase III transcripts and facilitates transcriptional 
termination and reinitiation by this enzyme13,-17. It has also 
been reported to function as an ATP-dependent helicase able 
to melt RNA-DNA hybrids18. La (SSB) may be involved in 
other processes as well such as maturation and/or nuclear 
export of RNA polymerase III products and some aspects of 
translation19,20. La (SSB) is a highly phosphorylated protein 
which migrates at about 50 kDa in SDS-polyacrylamide gel 
electrophoresis21. Phosphorylated residues are present at the 
carboxy-terminal part of the protein22. At least 8 isoelectric 
forms (pI range 6 to 7) have been identified23

The amino acid sequences of both human and bovine La 
(SSB) antigen have been determined by cDNA cloning and 
sequencing19,28. Comparison of the two sequences shows 22 
largely conservative amino acid substitutions with a total of 
95% identity. Three regions of the La molecule (amino acids 
1-107, 111-242 and 346-408) are thought to contain the major 
epitopes reactive with human anti-La sera19,24. The broad 
cross-reactivity of patient sera with La (SSB) from diverse 
mammalian species indicates the presence of conserved 
epitopes25. The use of bovine for the 
detection of human anti-La (SSB) antibodies has been 
described by several authors25-27
.
Methodology
The following is an ELISA procedure which can be used to 
detect anti-La (SSB) autoantibodies in human serum using the 
ATL01 purified autoantigen: 
1. Dilute the purified antigen to 0.5-1.0 µg/ml in PBS (10 mM 
potassium phosphate, pH 7.4, 0.15 M NaCl). 
2. Coat ELISA plates with 100 µl of diluted antigen per well. 
Cover and incubate 24 hours at +4o
C. 
3. Empty the plates and remove excess liquid by tapping on a 
paper towel. 
4. Block excess protein binding sites by adding 200 µl PBS 
containing 1% BSA per well. Cover and incubate at +4o

overnight. 
5. Empty plates and apply 100 µl of serum samples diluted 
1:100 in PBS / 1% BSA / 1% casein / 0.1% Tween?
 20. 
Incubate at room temperature for 1 hour. 
6. Empty plates and add 200 µl PBS / 0.1% Tween?
 20 per 
well. Incubate 5 minutes then empty plates. Repeat this step 
twice. 
7. Apply 100 µl anti-human IgG-enzyme conjugate 
(horseradish peroxidase or alkaline phosphatase) diluted in 
PBS / 1% BSA / 1% casein / 0.1% Tween?
 20 per well and 
incubate for 1 hour. 
8. Repeat step 6. 
9. Add enzyme substrate and stop the reaction when 
appropriate. 
10. Read absorbance in an ELISA spectrophotometer. 
References 
1. Molina, R. et al. (1986) Am. J. Med. 80, 23 
2. Bloch, K.J. et al. (1965) Medicine 44, 187 
3. Fox, R.I. et al. (1986) Arthritis Rheum. 29, 577 
4. Aziz, K.E. et al. (1992) Aust. NZ J. Med. 22, 671 
5. Manoussakis, M.N. et al. (1986) Scan. J. Rheumatol. 61, 89 
6. Harley, J.B. et al. (1986) Arthritis Rheum. 29, 196 
7. Craft, J.E. & Hardin, J.A. (1987) J. Rheumatol. 14 S13, 106 
8. St. Clair, E.W. (1992) Rheum. Dis. Clin. N. America 18, 359 
9. Harley, J.B. (1989) J. Autoimmun. 2, 383 
10. Buyon, J.P. et al. (1989) J. Clin. Invest. 84, 627 
11. Reichlin, M. (1986) J. Clin. Immunol. 6, 339 
12. Wiascewk, C.A. & Reichlin, M. (1982) J. Clin. Invest. 69, 835 
13. Stefano, J.E. (1984) Cell 36, 145 
14. Gottlieb, E. & Steitz, J.A. (1989) EMBO J. 8, 841 
15. Gottlieb, E. & Steitz, J.A. (1989) EMBO J. 8, 851 
16. Maraia, R.J. et al. (1994) Mol. Cell Biol. 14, 2147 
17. Maraia, R.J. (1996) Proc. Natl. Acad. Sci. USA 93, 3383 
18. Bachmann, M. et al. (1990) Cell 60, 85 
19. Chambers, J.C. et al. (1988) J. Biol. Chem. 263, 18043 
20. Bachmann, M. et al. (1989) Mol. Cell Biochem. 85, 103 
21. Pruijn, G.J.M. (1994) Man. Biol. Markers Dis. (Kluwer Acad. 
 Publ.) B4.2/1-14 
22. Pfeifle, J. et al. (1987) Biochim. Biophys. Acta 928, 217 
23. Francoeur, A.M. et al. (1985) mol. Cell Biol. 5, 586 
24. McNeilage, L.J. (1990) J. Immunol. 145, 3829 
25. Chan, E.K.L. & Tan, E.M. (1987) J. Exp. Med. 166, 1627 
26. Zhang, W. & Reichlin, M. (1996) Arthritis Rheum. 39, 522 
27. Chan, E.K.L. et al. (1986) J. Immunol. 136, 3744 
28. Chan, E.K.L. et al. (1989) Nucleic Acids Res. 17, 2233 
Micr-O-protect is from Roche Diagnostics GmbH (Mannheim, 
Germany). 
Tween?
 20 is a registered trademark of ICI Americas Inc. 
NOTE: No patented technology has been used by AroTec 
during the preparation of this product. 

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說(shuō)明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫(xiě)阿拉伯?dāng)?shù)字),如:三加四=7
上一條:Jo-1 antigen
下一條:Nucleosome antigen
www,con巨吊黄片| 黑人大吊性交孕妇啪啪啪| 国产精品久久久久av福利| 午夜精品视频在线观看视频| 人妻熟妇乱又伦精品hd| 孩子第一次做手术视频大全| 国产愉拍自愉免费第1页| 麻豆精品网一区二区三区| 91情侣偷在线精品国产| 日本一二三在线不卡视频| 美女扒开腿让男人捅视频| 日本精品啪啪一区二区三区| 美女日屄黄频道| 粉嫩高中生自慰网站免费| 肏逼流淫水视频| 丰满的人妻久久无码精品| 波多野结衣无码Av在线| 粉嫩av一区二区三区在线| 男生插女生下面在线观看| 男人爆操女网站| 免费网站www羞羞色污| 久久久国产精品免费观看| 精品在欧美一区二区少妇| 俄罗斯人操屄大视频网站| 一本一道久久久久久久久| 日本不卡片一区二区三区| 狂操东北农村人妻三级片| 爆操极品尤物熟妇14p| 久久―日本道色综合久久| 无遮挡粉嫩久久久久久久| 搞中出精品视频在线观看| 不要操进来视频| 妺妺跟我一起洗澡没忍住 | 淫荡的黑丝美女扣逼喷水| 2020亚洲精品视频在线| 久久机热这里只有精品首页| a国产欧美久久久不卡精品| 性感美女吃鸡巴在床上操| 儿童内裤上有黄色分泌物| 国产精品一区久久久久久| 久久精品动漫网一区二区|